J. Michiels

发表

Secondary Myelofibrosis in the Naturel History of JAK2, MPL and CALR Mutated Myeloproliferative Neoplasms

K. Schelfout, J. Michiels, F. Valster, 2015 .

The Erythrocyte Count on Top of Bone Marrow Histology Discriminates Essential Thrombocythemia and Polycythemia Vera in JAK2v617f Mutated Prefibrotic Myeloproliferative Neoplasm with No or Minor Splenomegaly

J. Lindemans, J. Michiels, W. Schroyens, 2014 .

Changing Concepts of Diagnostic Criteria of Myeloproliferative Disorders and the Molecular Etiology and Classification of Myeloproliferative Neoplasms: From Dameshek 1950 to Vainchenker 2005 and Beyond

Z. Berneman, H. de Raeve, J. Michiels, 2014, Acta Haematologica.

2014 WHO Clinical Molecular and Pathological (WHO-CMP) Diagnostic Criteria for the Classification and Staging of Five Distinct JAK2, MPL and CALR Mutated Myeloproliferative Neoplasms

K. Schelfout, J. Michiels, F. Valster, 2014 .

PVSG and WHO vs European Clinical, Molecular and Pathological Criteria for prefibrotic myeloproliferative neoplasms

Z. Berneman, J. Michiels, W. Schroyens, 2013 .

WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders.

Z. Berneman, K. Hebeda, H. de Raeve, 2007, Leukemia research.

Non-Invasive Diagnosis of Pulmonary Embolism, Anno 2005

H. Hoogsteden, P. Pattynama, J. Michiels, 2005, Acta chirurgica Belgica.

A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group

M. Griesshammer, T. Barbui, J. Reilly, 2007, Leukemia.

Classification and Characterization of Hereditary Types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (Unclassifiable) von Willebrand Disease

Z. Berneman, A. V. D. Van de Velde, A. Gadisseur, 2006, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Heparin-induced thrombocytopenia and thrombosis: a potential fatal complication in a routine treatment.

M. Kappers-Klunne, J. Michiels, H. V. van Vliet, 1995, The Netherlands journal of medicine.

Pseudohemophilia of Erik von Willebrand caused by homozygous one nucleotide deletion in exon 18 of the VW-factor gene

Z. Berneman, A. Gadisseur, J. Michiels, 2013 .

Laboratory Diagnosis and Molecular Basis of Mild von Willebrand Disease Type 1

Z. Berneman, A. Gadisseur, J. Michiels, 2009, Acta Haematologica.

Aspirin cures erythromelalgia and cerebrovascular disturbances in JAK2-thrombocythemia through platelet-cycloxygenase inhibition

J. Michiels, 2017 .

Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).

D. V. van Bockstaele, H. de Raeve, J. Michiels, 2007, Pathologie-biologie.

Thrombocytosis

C. Kessler, J. Michiels, 2019, Consultative Hemostasis and Thrombosis.

Clinical, pathological and molecular features of the chronic myeloproliferative disorders: MPD 2005 and beyond

J. Michiels, 2005, Hematology.

Novel Evidence-Based Diagnosis, Classification and Management of Lower Extremity Deep Vein Thrombosis (DVT), Prevention of DVT Recurrence and the Post-Thrombotic Syndrome: Personal Experiences and Critical Appraisal of the Literature 1998-2018

K. Roztočil, B. Cosmi, L. Gašpar, 2018 .

Diagnosis of deep vein thrombosis, and prevention of deep vein thrombosis recurrence and the post-thrombotic syndrome in the primary care medicine setting anno 2014.

G. Palareti, J. Michiels, Wim Moossdorff, 2015, World journal of critical care medicine.

Complete Compression Ultrsonography, Clinical Score, Underlying Risk Factors and D-Dimer Testing for Objective Evidence Based Diagnosis and Exclusion of Deep Vein Thrombosis and Alternative Diagnoses in the Primary Care and Hospital Setting

R. Strijkers, J. Michiels, P. Dulíček, 2015 .

Complete Compression Ultrsonography, Clinical Score, Underlying Risk

R. Strijkers, J. Michiels, P. Dulíček, 2015 .

Prospective Studies on Diagnosis, Prevention, and Management of Deep Vein Thrombosis (DVT), DVT Recurrence and the Post-Thrombotic Syndrome (PTS): From Concept to Study Design in the Primary Care Setting

M. Neumann, A. Markel, J. Michiels, 2014 .

Diagnosis of Deep Vein Thrombosis: How Many Tests Do we Need ?

Z. Berneman, J. Michiels, W. Schroyens, 2005, Acta chirurgica Belgica.

Exclusion and Diagnosis of Deep Vein Thrombosis by a Rapid ELISA D-dimer Test, Compression Ultrasonography, and a Simple Clinical Model

W. Oortwijn, J. Michiels, R. Naaborg, 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

The PVSG/WHO versus the Rotterdam European clinical, molecular and pathological diagnostic criteria for the classification of myeloproliferative disorders and myeloproliferative neoplasms (MPD/MPN): From Dameshek to Georgii, Vainchenker and Michiels 1950-2018

H. de Raeve, J. Michiels, Hendrik De Raeve, 2019, International Journal of Bone Marrow Research.

Aspirin responsive erythromelalgia in JAK2-thrombocythemia and incurable inherited erythrothermalgia in neuropathic Nav1.7 sodium channelopathy: from Mitchell 1878 to Michiels 2017

J. Michiels, 2017 .

Molecular pathobiology of aspirin responsive erythromelalgia in thrombocythemia and incurable inherited erythermalgia in Nav1.7mutated neuropathy

J. Michiels, 2017 .

Autosomal Dominant Hereditary Essential Thrombocythemia due to a Gain of Function Mutation in the Thrombopoietin (TPO) and JAK2 Gene as the Cause of Congenital Aspirin-Responsive Sticky Platelet Syndrome: Personal Experiences and Review of the Literature

J. Staško, A. Pich, J. Michiels, 2014 .

WHO Clinical Molecular and Pathological (WHO-CMP) Features of Congenital MPLS505N and the Acquired MPLW515l/K Mutated Essential Thrombocythemia and Myelofibrosis

J. Michiels, H. Raeve, J. Schwarz, 2014 .

Biology Diagnosis and Classification of MPD

Z. Berneman, K. Hebeda, J. Michiels, 2008 .

Doctor's Brochure 2004 Myeloproliferative Disorders: MPDs Essential Thrombocythemia: ET Polycythemia Vera: PV Chronic Idiopathic Myelofibrosis: IMF

J. Michiels, 2004 .

Spontaneous proliferative megakaryocytopoiesis and platelet hyperreactivity in essential thrombocythemia: is thrombopoietin the link?

S. Bellucci, J. Michiels, 2000, Annals of Hematology.

Different accuracies of rapid enzyme-linked immunosorbent, turbidimetric, and agglutination D-dimer assays for thrombosis exclusion: impact on diagnostic work-ups of outpatients with suspected deep vein thrombosis and pulmonary embolism.

H. Hoogsteden, P. Pattynama, A. Gadisseur, 2006, Seminars in thrombosis and hemostasis.

Phenotyping and Genotyping of Coagulation Factor V Leiden

J. Lindemans, L. Zwang, J. Michiels, 1996, Thrombosis and Haemostasis.

Strategies for the safe and effective exclusion and diagnosis of deep vein thrombosis by the sequential use of clinical score, D-dimer testing, and compression ultrasonography.

E. Van Beek, M. Janssen, G. Freyburger, 2000, Seminars in thrombosis and hemostasis.

Erythromelalgia and Vascular Complications in Polycythemia Vera

J. Michiels, J. Michiels, 1997, Seminars in thrombosis and hemostasis.

Dominant von Willebrand Disease Type 2A Groups I and II due to Missense Mutations in the A2 Domain of the von Willebrand Factor Gene: Diagnosis and Management

J. Michiels, H. V. van Vliet, 2009, Acta Haematologica.

Managing Patients with von Willebrand Disease Type 1, 2 and 3 with Desmopressin and von Willebrand Factor-Factor VIII Concentrate in Surgical Settings

Z. Berneman, A. Gadisseur, J. Michiels, 2009, Acta Haematologica.

Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.

Z. Berneman, A. V. D. Van de Velde, J. Michiels, 2002, Seminars in thrombosis and hemostasis.

Acquired von Willebrand Syndrome Type 1 in Hypothyroidism: Reversal After Treatment With Thyroxine

J. Michiels, W. Schroyens, M. G. Van der Planken, 2001, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII–von Willebrand factor concentrate (Haemate-P)

Z. Berneman, U. Budde, J. Michiels, 2004, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

High-dose Intravenous Immunoglobulin Delays Clearance of von Willebrand Factor in Acquired von Willebrand Disease

P. V. van Genderen, J. Michiels, W. Terpstra, 1995, Thrombosis and Haemostasis.

Prostaglandin cyclooxygenase products but not thromboxane A2 are involved in the pathogenesis of ewthromelalgia in thrombocythaemia

J. Michiels, F. Zijlstra, F. J. Zijlstra, 1993, Mediators of inflammation.

A de novo Deletion Causing εγδβ-Thalassemia in a Dutch Patient

L. Bernini, T. Huisman, N. S. Smetanina, 1996 .

Full-dose chemotherapy for non-Hodgkin's lymphoma in the elderly. Dutch Hematology-Oncology in Adults Study Group.

P. Sonneveld, G. Blijham, W. Hop, 1994, Seminars in hematology.

Analysis of von Willebrand Disease in the South Moravian Population (Czech Republic): Results from the BRNO-VWD Study

J. Blatny, Z. Berneman, P. Smejkal, 2019, Thrombosis and Haemostasis.

Richter's syndrome with identical immunoglobulin gene rearrangements in the chronic lymphocytic leukemia and the supervening non-Hodgkin lymphoma.

T. H. van der Kwast, P. Sonneveld, A. Hagemeijer, 1989, Leukemia.

Richter's syndrome with different immunoglobulin light chains and different heavy chain gene rearrangements.

T. H. van der Kwast, A. Hagemeijer, J. V. van Dongen, 1984, Blood.

Heparin-Induced Thrombocytopenia with Multiple Cerebral Infarctions Simulating Thrombotic Thrombocytopenic Purpura A Case Report

M. Kappers-Klunne, H. Tanghe, J. Michiels, 1996, Angiology.

Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.

Z. Berneman, U. Budde, J. Michiels, 2001, Best practice & research. Clinical haematology.

Diagnosis and Treatment of Polycythemia Vera and Possible Future Study Designs of the PVSG

T. Barbui, A. Tefferi, R. Silver, 2000, Leukemia & lymphoma.

Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.

A. Green, M. Griesshammer, P. V. van Genderen, 1999 .

Principles for Accurate Diagnosis of Deep Vein Thrombosis (DVT) and Prevention of DVT Recurrence and the Post-Thrombotic Syndrome in the Primary Care and Hospital Medicine

M. Neumann, J. Michiels, J. Michiels, 2018 .

Diagnosis and treatment of DVT and prevention of DVT recurrence and the PTS: bridging the gap between DVT and PTS in the primary care setting or outpatient ward

G. Palareti, P. Poredos, H. Neumann, 2017 .

Duplex Ultrasound, Clinical Score, and D-Dimer to Rule in and Out Deep Venous Thrombosis (DVT) and Postthrombotic Syndrome (PTS): Bridging the Gap between DVT and PTS in the Primary Care and Hospital Setting

J. Michiels, J. Michiels, M. Lao, 2015 .

PROSPECTIVE STUDIES ON DIAGNOSIS AND MANAGEMENT OF DEEP VEIN THROMBOSIS ( DVT ) AND THE POST-THROMBOTIC SYNDROME ( PTS ) : FILLING UP THE GAP PART 1 : DEEP-VEIN THROMBOSIS ( DVT ) : THE ROTTERDAM

H. Neumann, J. Michiels, S. W. I. Reeder-Boertje, 2009 .

Non-invasive diagnosis of deep vein thrombosis

J. Michiels, W. Schroyens, M. V. Planken, 2003 .

Safe Exclusion of Deep Vein Thrombosis by a Rapid Sensitive ELISA D-dimer and Compression Ultrasonography in 1330 Outpatients With Suspected DVT

J. Michiels, W. Schroyens, Wim Moossdorff, 2016, Angiology.

Clinicopathological diagnosis and differential criteria of thrombocythemias in various myeloproliferative disorders by histopathology, histochemistry and immunostaining from bone marrow biopsies.

V. Diehl, J. Thiele, R. Fischer, 1999, Leukemia & lymphoma.

Platelet Consumption in Thrombocythemia Complicated by Erythromelalgia: Reversal by Aspirin

P. V. van Genderen, J. Lindemans, R. van Strik, 1995, Thrombosis and Haemostasis.

[A family with venous thrombosis and hereditary protein S deficiency].

R. Bertina, J. Michiels, L. Engesser, 1987, Nederlands tijdschrift voor geneeskunde.

The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.

Z. Berneman, D. V. van Bockstaele, K. Hebeda, 2006, Seminars in thrombosis and hemostasis.

Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: A distinct aspirin-responsive and coumadin-resistant arterial thrombophilia

P. Koudstaal, Z. Berneman, J. Lindemans, 2006, Platelets.

Bone marrow histology in CALR mutated thrombocythemia and myelofibrosis: results from two cross sectional studies in 70 newly diagnosed JAK2/MPL wild type thrombocythemia patients

Yonggoo Kim, Z. Berneman, Myungshin Kim, 2019, International Journal of Bone Marrow Research.

Primary myelo fi brosis is not primary anymore since the discovery of MPL 515 and CALR mutations as driver causes of mono-linear megakaryocytic and dual megakaryocytic granulocytic myeloproliferation and secondary myelo fi brosis

J. Michiels, H. Raeve, 2019 .

Bone Marrow Histology is a Pathognomonic Clue to Each of the JAK2 V617F , MPL,515 and Calreticulin Mutated Thrombocythemia in Myeloproliferative Neoplasms

Z. Berneman, Myungshin Kim, Y. Kim, 2018 .

Myelofibrosis is a Secondary Event in JAK2 Trilinear Myeloproliferative Neoplasm (MPN) and in CALR and MPL Thrombocythemia: Implications for Novel Treatment Options of Prefibrotic MPN

K. Schelfout, Z. Berneman, A. Gadisseur, 2017 .

Extension of 2016 World Health Organization (WHO) Classification into a New Set of Clinical, Laboratory, Molecular, and Pathological Criteria for the Diagnosis of Myeloproliferative Neoplasms: From Dameshek to Vainchenker, Green, and Kralovics

Yonggoo Kim, Myungshin Kim, H. de Raeve, 2017, European Medical Journal.

A critical appraisal of non-invasive diagnosis and exclusion of deep vein thrombosis and pulmonary embolism in outpatients with suspected deep vein thrombosis or pulmonary embolism: how many tests do we need?

H. Hoogsteden, P. Pattynama, A. Gadisseur, 2005, International angiology : a journal of the International Union of Angiology.

Diagnostic criteria of the myeloproliferative disorders (MPD): essential thrombocythaemia, polycythaemia vera and chronic megakaryocytic granulocytic metaplasia.

J. Michiels, 1997, The Netherlands journal of medicine.

Polycythemia Vera era 1939-1998 from Berkeley to Rotterdam and Change of PVSG into ECP Criteria of Myeloproliferative Disorders ET, PV and PMGM: Proceedings of the First Rotterdam MPD Workshop 1998 and beyond

J. Michiels, 2017 .

Bone Marrow Features and Natural History of BCR/ABL-Positive Thrombocythemia and Chronic Myeloid Leukemia Compared to BCR/ABLNegative Thrombocythemia in Essential Thrombocythemia and Polycythemia Vera

A. Gadisseur, J. Michiels, F. Kate, 2015 .

The European Clinical, Molecular, and Pathological (ECMP) Criteria and the 2007/2008 Revisions of the World Health Organization for the Diagnosis, Classification, and Staging of Prefibrotic Myeloproliferative Neoplasms Carrying the JAK2V617F Mutation

Z. Berneman, H. de Raeve, J. Michiels, 2014, Turkish Journal of Hematology.

JAK2V617F positive early stage myeloproliferative disease (essential thrombocythemia) as the cause of portal vein thrombosis in two middle-aged women: therapeutic implications in view of the literature

S. Commandeur, J. Michiels, H. Raeve, 2007, Annals of Hematology.

Pathophysiology and treatment of platelet-mediated microvascular disturbances, major thrombosis and bleeding complications in essential thrombocythaemia and polycythaemia vera.

Z. Berneman, J. Michiels, W. Schroyens, 2004, Platelets.

Bone marrow histopathology and biological markers as specific clues to the differential diagnosis of essential thrombocythemia, polycythemia vera and prefibrotic or fibrotic agnogenic myeloid metaplasia.

J. Michiels, 2004, The hematology journal : the official journal of the European Haematology Association.

Platelet-mediated microvascular inflammation and thrombosis in thrombocythemia vera: a distinct aspirin-responsive arterial thrombophilia, which transforms into a bleeding diathesis at increasing platelet counts.

J. Michiels, 2003, Pathologie-biologie.

Erythromelalgia: A Pathognomonic Microvascular Thrombotic Complication in Essential Thrombocythemia and Polycythemia Vera

P. V. van Genderen, J. Michiels, 1997, Seminars in thrombosis and hemostasis.

Aspirin in Essential Thrombocythemia: Status Quo and Quo Vadis

M. Bangerter, M. Griesshammer, J. Michiels, 1997, Seminars in thrombosis and hemostasis.

Proposal for Revised Diagnostic Criteria of Essential Thrombocythemia and Polycythemia Vera by the Thrombocythemia Vera Study Group

E. Juvonen, J. Michiels, 1997, Seminars in thrombosis and hemostasis.

Thrombocythemia and coronary artery disease.

M. Simoons, J. Roelandt, M. Scheffer, 1991, American heart journal.

Venous Thrombophilia, Platelet von Willebrand Factor Mediated Arteriolar Microvascular Thrombosis in JAK2V617F Mutated Thrombocythemia and Acquired ADAMTS13 Deficiency as Causes of Intrahepatic Obstructive Microvascular Liver Diseases in Budd-Chiari Syndrome and Splanchnic Vein Thrombosis

J. Michiels, 2018, Journal of Cardiology and Cardiovascular Sciences.

Acquired von Willebrand disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemia: Relationship with platelet count

J. Michiels, P. V. Genderen, H. Vliet, 1994, Annals of Hematology.

Primary thrombocythemia: diagnosis, clinical manifestations and management

J. Michiels, P. V. Genderen, P. Genderen, 1993, Annals of Hematology.

Excessive prolongation of the bleeding time by aspirin in essential thrombocythemia is related to a decrease of large von Willebrand factor multimers in plasma

P. V. van Genderen, R. van Strik, U. Budde, 1997, Annals of Hematology.

Acquired von Willebrand disease in myeloproliferative disorders.

P. V. van Genderen, U. Budde, J. Michiels, 1996, Leukemia & lymphoma.

Bleeding time and platelet function in essential thrombocythemia and other myeloproliferative syndromes.

G. Finazzi, U. Budde, J. Michiels, 1996, Leukemia & lymphoma.

Transient neurologic and ocular manifestations in primary thrombocythemia

P. Koudstaal, A. Mulder, J. Michiels, 1993, Neurology.

Aspirin-Responsive, Migraine-Like Transient Cerebral and Ocular Ischemic Attacks and Erythromelalgia in JAK2V617F-Positive Essential Thrombocythemia and Polycythemia Vera

Z. Berneman, H. de Raeve, A. Gadisseur, 2014, Acta Haematologica.

Angiotensin converting enzyme: a tumour marker in malignant histiocytosis.

F. Boomsma, M. Schalekamp, J. Abels, 1983, British medical journal.

PROSPECTIVE STUDIES ON DIAGNOSIS AND MANAGEMENT OF DEEP VEIN THROMBOSIS ( DVT ) AND THE POST-THROMBOTIC SYNDROME ( PTS ) : FILLING UP THE GAP PART 2 : POST-THROMBOTIC SYNDROME : THE ROTTERDAM APPROACH DEFINITION

H. Neumann, J. Michiels, S. W. I. Reeder-Boertje, 2009 .

Hydroxyurea in essential thrombocytosis.

P. V. van Genderen, J. Michiels, Van Genderen Pj, 1995, The New England journal of medicine.

Erythromelalgic, thrombotic and haemorrhagic manifestations of thrombocythaemia.

P. V. van Genderen, J. Michiels, P. Genderen, 1994, Presse medicale.

The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.

Z. Berneman, G. Finazzi, U. Budde, 2006, Seminars in thrombosis and hemostasis.

T-lymphoblastic lymphoma terminating as malignant histiocytosis with rearrangement of immunoglobulin heavy chain gene.

T. H. van der Kwast, A. Hagemeijer, J. V. van Dongen, 1991, Leukemia.

Essential Differences in Clinical and Bone Marrow Features in BCR/ABL-Positive Thrombocythemia Compared to Thrombocythemia in the BCR/ABL-Negative Myeloproliferative Neoplasms Essential Thrombocythemia and Polycythemia Vera

H. de Raeve, A. Gadisseur, A. Pich, 2014, Acta Haematologica.

Aspirin-responsive painful red, blue, black toe, or finger syndrome in polycythemia vera associated with thrombocythemia

Z. Berneman, H. Urk, J. Michiels, 2003, Annals of Hematology.

Acquired von Willebrand Disease Due to Increasing Platelet Count Can Readily Explain the Paradox of Thrombosis and Bleeding in Thrombocythemia

J. Michiels, 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Thromboxane‐dependent platelet activation in vivo precedes arterial thrombosis in thrombocythaemia: a rationale for the use of low‐dose aspirin as an antithrombotic agent

P. V. van Genderen, K. Schrör, J. Michiels, 1999, British journal of haematology.

Erythromelalgia in Essential Thrombocythemia Is Characterized by Platelet Activation and Endothelial Cell Damage but not by Thrombin Generation

P. V. van Genderen, R. van Strik, V. Vuzevski, 1996, Thrombosis and Haemostasis.

Atypical transient ischemic attacks in thrombocythemia of various myeloproliferative disorders.

P. V. van Genderen, P. Koudstaal, J. Michiels, 1996, Leukemia & lymphoma.

Erythromelalgia and thrombocythemia: a causal relation.

J. Michiels, T. van Joost, 1990, Journal of the American Academy of Dermatology.

Histopathology of erythromelalgia in thrombocythaemia

J. Abels, V. Vuzevski, J. Michiels, 1984, Histopathology.

Signs and Symptoms of Myeloproliferative Neoplasms (MPN), Quality of Life, Social Activity, Work Participation and the Impact of Fatigue in Dutch MPN Patients: A One Country Questionnaire Investigation of 497 MPN Patients

J. Michiels, 2015 .

Erythromelalgic Microvascular Disturbances, Major Thrombosis and Hemorrhagic Manifestations of Thrombocythemia in Patients with Essential Thrombocythemia and Polycythemia Vera: Therapeutic Implications

J. Michiels, 2014 .

Bilateral adrenal swelling as a cause of chest, back, and upper abdominal pain in essential thrombocythemia and polycythemia vera is due to microvascular ischemic thrombosis rather than to hemorrhage

G. Krestin, Z. Berneman, J. Michiels, 2002, Annals of Hematology.

State-of-the-Art Review : Effectiveness of Anagrelide in the Treatment of Symptomatic Patients with Essential Thrombocythemia

R. Marta, F. Molinas, J. Michiels, 2000, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Arterial Thrombophilia in Primary Thrombocythemia

P. V. van Genderen, J. Michiels, 1994 .

ERYTHROMELALGIA AND ERYTHERMALGIA: LUMPERS AND SPLITTERS

J. Michiels, J. Drenth, 1994, International journal of dermatology.

Erythromelalgia and Arterial Thrombophilia in Thrombocythemia

J. Michiels, P. V. Genderen, H. Vliet, 1994, Annals of the New York Academy of Sciences.

Hereditary antithrombin III deficiency and venous thrombosis.

J. Michiels, H. V. van Vliet, 1984, The Netherlands journal of medicine.

Recessive von Willebrand Disease Type 2 Normandy: Variable Expression of Mild Hemophilia and VWD Type 1

Z. Berneman, A. Gadisseur, J. Michiels, 2009, Acta Haematologica.

Platelet-mediated thrombotic complications in patients with ET: Reversal by aspirin, platelet reduction, and not by coumadin.

P. Koudstaal, Z. Berneman, J. Lindemans, 2006, Blood cells, molecules & diseases.

Aspirin Responsive Thrombotic Complications in Thrombocythemia Vera. A Novel Platelet-Mediated Arterial Thrombophilia.

J. Michiels, 2002, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Acquired von Willebrand Disease at Increasing Platelet count as a Cause of Hemorrhagic Thrombocythemia in Various Myeloproliferative Disorders

J. Michiels, 1998 .

CLASSIFICATION AND DIAGNOSIS OF ERYTHROMELALGIA AND ERYTHERMALGIA

J. Drenth, J. Michiels, P. V. Genderen, 1995, International journal of dermatology.

ERYTHROMELALGIA AND ERYTHERMALGIA: DIAGNOSTIC DIFEERENTIATION

J. Michiels, J. Drenth, 1994, International journal of dermatology.

Erythromelalgia in thrombocythemia of various myeloproliferative disorders

F. ten Kate, J. Michiels, 1992, American journal of hematology.

Erythromelalgia versus erythermalgia

J. Michiels, 1990, The Lancet.

Amplification of the c-myc and the pvt-like region in human multiple myeloma.

R. Benner, J. Michiels, M. Bakkus, 1990, Oncogene.

Myeloproliferative and thrombotic burden and treatment outcome of thrombocythemia and polycythemia patients.

J. Michiels, 2015, World journal of critical care medicine.

Renal AA amyloidosis in a patient with Bence Jones proteinuria and ankylosing spondylitis.

P. Siersema, F. T. ten Kate, J. Michiels, 1992, Journal of clinical pathology.

Multiple myeloma and acute megakaryoblast leukemia in spent phase polycythemia vera.

A. Hagemeijer, O. Meuwissen, J. Michiels, 1990, American journal of clinical pathology.

Acquired Von Willebrand Syndrome (AVWS) Type 2A as the Presenting Feature of JAK2 Wild type Thrombocythemia in a Child: Effectiveness of Platelet Reduction by Anagrelide

U. Budde, J. Michiels, T. Kuehn, 2017 .

Philadelphia (Ph) chromosome-positive thrombocythemia without features of chronic myeloid leukemia in peripheral blood: natural history and diagnostic differentiation from Ph-negative essential thrombocythemia

Z. Berneman, B. Ridell, B. Swolin, 2004, Annals of Hematology.

arboxypeptidase U at the Interface Between Coagulation and Fibrinolysis

F. Goossens, R. Verkerk, J. Michiels, 2001 .

Decreased half‐life time of plasma von Willebrand factor collagen binding activity in essential thrombocythaemia: normalization after cytoreduction of the increased platelet count

P. V. van Genderen, R. van Strik, J. Michiels, 1997, British journal of haematology.

Prophylaxis of thrombosis in antithrombin III-deficient women during pregnancy and delivery.

E. Vellenga, J. Michiels, H. V. van Vliet, 1984, European journal of obstetrics, gynecology, and reproductive biology.

Acquired von Willebrand Disease in Monoclonal Gammapathies: Effectiveness of High-dose Intravenous Gamma Globulin

J. Michiels, H. V. van Vliet, 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Comparison of Von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo.

C. Heilmann, B. Zieger, J. Michiels, 2014, Thrombosis research.

Application of PRV-1 mRNA expression level and JAK2V617F mutation for the differentiating between polycytemia vera and secondary erythrocytosis and assessment of treatment by interferon or hydroxyurea

J. Rozenberg, J. Michiels, E. Semenova, 2007, Hematology.

Essential thrombocythaemia is not associated with postpartum thrombosis or an increased risk of venous thromboembolism

J. Michiels, 1998, European journal of haematology.

Full dose chemotherapy in elderly patients with non-Hodgkin's lymphoma: a feasibility study using a mitoxantrone containing regimen.

P. Sonneveld, J. Michiels, 1990, British Journal of Cancer.

Duplex ultrasound, clinical score, thrombotic risk, and D-dimer testing for evidence based diagnosis and management of deep vein thrombosis and alternative diagnoses in the primary care setting and outpatient ward.

G. Palareti, V. Štvrtinová, H. Neumann, 2014, International angiology : a journal of the International Union of Angiology.

Erythromelalgic, thrombotic and hemorrhagic manifestations in 50 cases of thrombocythemia.

P. V. van Genderen, J. Lindemans, J. Michiels, 1996, Leukemia & lymphoma.

Vertebral bone destruction in sickle cell disease: infection, infarction or both.

A. T. Ten Tije, J. Kluytmans, H. Tanghe, 1996, The Netherlands journal of medicine.

Erythromelalgic Thrombotic Thrombocythemia (ETT) and Hemorrhagic Trombocythemia (HT) in Patients with Essential Thrombocythaemia (ET) and Polycythaemia Vera (PV)

J. Michiels, 2014 .

Acute secondary erythermalgia and hypertension in children

J. Drenth, J. Michiels, S. Özsoylu, 1995, European Journal of Pediatrics.

Cutaneous pathology in primary erythermalgia.

J. Vermylen, J. Drenth, V. Vuzevski, 1996, The American Journal of dermatopathology.

Secondary erythermalgia associated with an autoimmune disorder of undetermined significance.

J. Drenth, V. Vuzevski, J. Michiels, 1995, Dermatology.

Thrombocythemic erythromelalgia, primary erythermalgia, and secondary erythermalgia: three distinct clinicopathologic entities.

P. V. van Genderen, J. Drenth, J. Michiels, 1994, Angiology.

Erythromelalgia Versus Primary and Secondary Erythermalgia

J. Michiels, J. Drenth, 1994, Angiology.

Arterial thrombosis in thrombocythemia.

P. Koudstaal, J. Roelandt, J. Michiels, 1993, American heart journal.

Hereditary erythermalgia and acquired erythromelalgia.

P. V. van Genderen, J. Drenth, J. Michiels, 1993, American journal of medical genetics.

Clinical characteristics and pathophysiology of erythromelalgia and erythermalgia.

J. Drenth, J. Michiels, 1992, The American journal of medicine.

Idiopathic erythermalgia: a congenital disorder.

V. Vuzevski, J. Michiels, T. van Joost, 1989, Journal of the American Academy of Dermatology.

Aspirin Resistant Autosomal Dominant Familial Erythermalgia: A Congenital Incurable Neuropathic Disorder Caused by a Gain of Function Mutation in Exon 26 of the SCN9a Gene on Chromosome 2q24.3

J. Michiels, 2014 .

Acquired von Willebrand Syndrome: Experience from 2 Years in a Single Laboratory Compared with Data from the Literature and an International Registry

U. Budde, F. Bergmann, J. Michiels, 2002, Seminars in thrombosis and hemostasis.

Intravenous DDAVP and Factor VIII-von Willebrand Factor Concentrate for the Treatment and Prophylaxis of Bleedings in Patients With von Willebrand Disease Type 1, 2 and 3

Z. Berneman, U. Budde, A. Gadisseur, 2007, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

A cluster of mutations in the D3 domain of von Willebrand factor correlates with a distinct subgroup of von Willebrand disease: type 2A/IIE.

R. Schneppenheim, B. Zieger, U. Budde, 2010, Blood.

Laboratory Diagnosis and Molecular Classification of von Willebrand Disease

Cedric Hermans, C. Hermans, Z. Berneman, 2009, Acta Haematologica.

Analysis of von Willebrand Disease in the “Heart of Europe”

J. Blatny, Z. Berneman, P. Smejkal, 2022, TH open : companion journal to thrombosis and haemostasis.

Laboratory and Molecular Characteristics of Recessive von Willebrand Disease Type 2C (2A Subtype IIC) of Variable Severity due to Homozygous or Double Heterozygous Mutations in the D1 and D2 Domains

Z. Berneman, A. Gadisseur, J. Michiels, 2009, Acta Haematologica.

Acquired von Willebrand Syndrome in Systemic Lupus Erythematodes

J. Michiels, W. Schroyens, M. G. Van der Planken, 2001, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

3 Acquired von Willebrand disease

J. Michiels, P. V. Genderen, P. Genderen, 1998 .

Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder.

J. Michiels, P. V. Genderen, P. Genderen, 1978 .

Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.

Z. Berneman, U. Budde, A. V. D. Van de Velde, 2005, Seminars in thrombosis and hemostasis.

Characterization of Recessive Severe Type 1 and 3 von Willebrand Disease (VWD), Asymptomatic Heterozygous Carriers Versus Bloodgroup O-Related von Willebrand Factor Deficiency, and Dominant Type 1 VWD

Z. Berneman, A. V. D. Van de Velde, A. Gadisseur, 2006, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Erythroleukemia and myelodysplastic syndromes: an historical appraisal and a personal view.

J. Michiels, 1993, Leukemia & lymphoma.

Autosomal dominant erythermalgia associated with a novel mutation in the voltage-gated sodium channel alpha subunit Nav1.7.

J. Drenth, J. Jansen, J. Michiels, 2005, Archives of neurology.

Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia.

J. Steketee, J. Abels, V. Vuzevski, 1985, Annals of internal medicine.

The primary erythermalgia-susceptibility gene is located on chromosome 2q31-32.

R. L. Kirby, P. Heutink, J. Drenth, 2001, American journal of human genetics.

Treatment options in primary erythermalgia?

J. Michiels, J. Drenth, 1993, American journal of hematology.

TdT positive B‐cell acute lymphoblastic leukaemia (B‐ALL) without Burkitt characteristics

A. Hagemeijer, J. V. van Dongen, J. Abels, 1988, British journal of haematology.

Pseudohyperkalaemia in thrombocythaemia.

R. Wulkan, J. Michiels, 1990, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

Effectiveness of long term oral anticoagulation treatment in preventing venous thrombosis in hereditary protein S deficiency.

R. Bertina, A. Broekmans, J. Michiels, 1987, British medical journal.

Coumarin Induced and Spontaneous Hemorrhagic Skin Necrosis

J. Michiels, F. Kate, 2016 .

Clinical and Pathological Criteria for the Diagnosis of Essential Thrombocythemia, Polycythemia Vera, and Idiopathic Myelofibrosis (Agnogenic Myeloid Metaplasia)

Juergen Thiele, J. Thiele, Jan Jacques Michiels, 2002, International journal of hematology.

A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group

M. Griesshammer, T. Barbui, J. Reilly, 2007, Leukemia.

Case report: mammographic and sonographic demonstration of extramedullary haematopoiesis of the breast.

H. Zonderland, F. T. ten Kate, J. Michiels, 1991, Clinical radiology.

Renal insufficiency due to bilateral primary renal lymphoma.

T. van Gelder, M. Schalekamp, A. Mulder, 1992, Nephron.

The role of JAK2 V617F mutation, spontaneous erythropoiesis and megakaryocytopoiesis, hypersensitive platelets, activated leukocytes, and endothelial cells in the etiology of thrombotic manifestations in polycythemia vera and essential thrombocythemia.

S. Bellucci, J. Michiels, 2006, Seminars in thrombosis and hemostasis.

Simple monosomy 7 and myelodysplastic syndrome in thirteen patients without previous cytostatic treatment

A. Hagemeijer, K. Hählen, J. Michiels, 1986, British journal of haematology.

Acquired disorders of haemostasis : pathophysiology, clinical practice and basic research

J. Michiels, 1998 .

Acquired von Willebrand disease caused by an autoantibody selectively inhibiting the binding of von Willebrand factor to collagen.

P. V. van Genderen, J. Sixma, T. Vink, 1994, Blood.

Novel European Asiatic Clinical, Laboratory, Molecular and Pathobiological (2015-2020 CLMP) criteria for JAK2V617F trilinear polycythemia vera (PV), JAK2exon12 PV and JAK2V617F, CALR and MPL515 thrombocythemias: From Dameshek to Constantinescu-Vainchenker, Kralovics and Michiels

A. Trifa, Kim， Dong-Wook, A. Pich, 2020, International Journal of Bone Marrow Research.

Acquired Hemophilia A in Women Postpartum: Clinical Manifestations, Diagnosis, and Treatment

J. Michiels, J. Michiels, 2000, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Classification and Characterization of Hereditary Types 2 A , 2 B , 2 C , 2 D , 2 E , 2 M , 2 N , and 2 U ( Unclassifiable ) von Willebrand Disease

Z. Berneman, A. Gadisseur, J. Michiels, 2006 .

Laboratory Diagnosis of von Willebrand Disease Type 1/2E (2A Subtype IIE), Type 1 Vicenza and Mild Type 1 Caused by Mutations in the D3, D4, B1–B3 and C1–C2 Domains of the von Willebrand Factor Gene

Z. Berneman, A. Gadisseur, J. Michiels, 2009, Acta Haematologica.

Diagnostic Differentiation of von Willebrand Disease Types 1 and 2 by von Willebrand Factor Multimer Analysis and DDAVP Challenge Test

P. Smejkal, M. Penka, U. Budde, 2017, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Changing insights in the diagnosis and classification of autosomal recessive and dominant von Willebrand diseases 1980-2015

P. Smejkal, M. Penka, A. Gadisseur, 2016 .

High-dose intravenous gammaglobulin therapy for acquired von Willebrand disease.

P. V. van Genderen, D. Papatsonis, F. Huikeshoven, 1994, Postgraduate medical journal.

Dominant von Willebrand Disease Type 2M and 2U Are Variable Expressions of One Distinct Disease Entity Caused by Loss-of-Function Mutations in the A1 Domain of the von Willebrand Factor Gene

Z. Berneman, A. Gadisseur, J. Michiels, 2009, Acta Haematologica.

Causes, Etiology and Diagnosis of Acquired von Willebrand Disease: A Prospective Diagnostic Workup to Establish the Most Effective Therapeutic Strategies

R. Zotz, C. Sucker, J. Michiels, 2009, Acta Haematologica.

The myeloproliferative disorders. An historical appraisal and personal experiences.

J. Michiels, J. J. Michiels, 1996, Leukemia & lymphoma.

Normal Life Expectancy and Thrombosis-Free Survival in Aspirin Treated Essential Thrombocythemia

J. Michiels, J. Michiels, 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.

Z. Berneman, D. V. van Bockstaele, H. de Raeve, 2006, Seminars in thrombosis and hemostasis.

Atypical Variant of Acquired von Willebrand Syndrome in Wilms Tumor: Is Hyaluronic Acid Secreted by Nephroblastoma Cells the Cause?

J. Michiels, W. Schroyens, M. G. Van der Planken, 2001, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Aspirin and Platelet-Lowering Agents for the Prevention of Vascular Complications in Essential Thrombocythemia

J. Michiels, J. Michiels, 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Secondary erythermalgia in systemic lupus erythematosus; [comment].

J. Drenth, V. Vuzevski, J. Michiels, 1993, The Journal of rheumatology.

Verapamil‐induced secondary erythermalgia

J. Drenth, V. Vuzevski, J. Michiels, 1992, The British journal of dermatology.

Three types of erythromelalgia.

J. Drenth, J. Michiels, 1990, BMJ.

Primary and secondary erythermalgia, a critical review.

J. Michiels, T. van Joost, 1988, Netherlands Journal of Medicine.

Erythermalgia secondary to vasculitis.

J. Drenth, V. Vuzevski, J. Michiels, 1993, The American journal of medicine.

[From gene to disease; primary erythermalgia--a neuropathic disease as a consequence of mutations in a sodium pump gene].

J. Drenth, R. te Morsche, J. Michiels, 2006, Nederlandsch tijdschrift voor geneeskunde.

Effectiveness of High‐Dose Intravenous Gamma Globulin Therapy in Acquired von Willebrand's Disease

J. Michiels, J. Bakker, M. Veer, 1994, Vox sanguinis.

Thrombocythaemic erythromelalgia in chronic myeloproliferative and myelodysplastic disorders.

J. Michiels, M. Prins, A. Hagemeyer, 1989, The Netherlands journal of medicine.

Increased Erythrocyte Count on Top of Bone Marrow Histology but not Serum EPO Level or JAK2 Mutation Load Discriminates between JAK2V617F Mutated Essential Thrombocythemia and Polycythemia Vera

K. Schelfout, M. Medinger, J. Michiels, 2015 .

Aspirin responsive platelet thrombophilia in essential thrombocythemia and polycythemia vera

P. Koudstaal, J. Michiels, F. Kate, 2013 .

The European clinical, molecular and pathological (Euro cmp → CMP) and WHO-CMP criteria of the myeloproliferative disorders 1940-2008 and myeloproliferative neoplasms 2008-2015

J. Michiels, H. Raeve, 2016 .

Screening for deep vein thrombosis and pulmonary embolism in outpatients with suspected DVT or PE by the sequential use of clinical score: a sensitive quantitative D-dimer test and noninvasive diagnostic tools.

H. Hoogsteden, P. Pattynama, A. Gadisseur, 2005, Seminars in vascular medicine.

The Paradox of Bleeding and Thrombosis in Thrombocythemia: Is von Willebrand Factor the Link?

P. V. van Genderen, J. Michiels, J. Michiels, 1997, Seminars in thrombosis and hemostasis.

Carboxypeptidase U at the interface between coagulation and fibrinolysis.

F. Goossens, R. Verkerk, J. Michiels, 2001, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Combined Use of Rapid Von Willebrand Factor (VWF) Activity,VWF-Propetide and Classical VWF Assays for Improved Diagnosisof Von Willebrand Disease Type 1, 2N and 2E Due to Mutations inthe D1, D2, D’, D3 and D4 Domains of the VWF Gene

Z. Berneman, P. Smejkal, M. Penka, 2019 .

Determination of Two Rapid Von Willebrand Factor (VWF) Activity assays VWF: Gpibm and VWF: Gpibr in Well Defined Von Willebrand Disease Patients Using a Complete Set of Classical and Sensitive VWF Assays

P. Smejkal, M. Penka, G. Moore, 2018 .

Guidelines for the evaluation of intravenous desmopressin and von Willebrand factor/factor VIII concentrate in the treatment and prophylaxis of bleedings in von Willebrand disease types 1, 2, and 3.

Z. Berneman, A. Gadisseur, J. Michiels, 2006, Seminars in thrombosis and hemostasis.

Diagnosis, etiology and management of the Budd-Chiari Syndrome: a bloodcoagulation and hepatological study on the course of the disease treated with TIPS.

P. Žák, P. Hůlek, A. Krajina, 2016, International angiology : a journal of the International Union of Angiology.

Three Phenotypes of JAKV617F Mutated Essential Thrombocythemia and Early Thrombocythemic Stage of Polycythemia Vera in 10 Patients: Important to Differentiate because Natural History Differ

Z. Berneman, K. Hebeda, K. Lom, 2015 .

PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2

F. Leebeek, M. Kappers-Klunne, J. Michiels, 2008, Thrombosis and Haemostasis.

Myeloproliferative Neoplasm Quality of Life (MPN-QOL) Study Group: Interim Results from the MPN Experimental Assessment of Symptoms By Utilizing Repetitive Evaluation (MEASURE) Trial

N. Zhang, E. Ejerblad, A. Dueck, 2016 .

Immune-mediated etiology of acquired von Willebrand syndrome in systemic lupus erythematosus and in benign monoclonal gammopathy: therapeutic implications.

Z. Berneman, U. Budde, A. Gadisseur, 2006, Seminars in thrombosis and hemostasis.

Philadelphia chromosome-positive thrombocythemia and megakaryoblast leukemia.

P. Brederoo, J. Abels, J. Michiels, 1987, American journal of clinical pathology.

The natural history of trilinear myelodysplastic syndrome and erythroleukemia.

P. Brederoo, J. Michiels, J. Van der Meulen, 1997, Haematologica.

European Clinical Laboratory, Molecular and Pathological (ECMP) criteria for prefibrotic JAK2V617F-Thrombocythemia and Polycythemia Vera versus MPL515- and CALR-Thrombocythemia and Myelofibrosis: From Dameshek to Michiels 1950-2018

Z. Berneman, Michiels Jan Jacques, J. Michiels, 2019, International Journal of Bone Marrow Research.

Preface

J. Michiels, 1997 .

A de novo deletion causing epsilon gamma delta beta-thalassemia in a Dutch patient.

L. Bernini, T. Huisman, N. S. Smetanina, 1996, Acta haematologica.

The 2006 → 2008 European Clinical, Molecular and Patholobiogical (2008 ECMP) Classification and the 2007 WHO Revised Criteria for Myeloproliferative Neoplasms

K. Schelfout, Z. Berneman, K. Hebeda, 2015 .

Exclusion and diagnosis of deep vein thrombosis in outpatients by sequential noninvasive tools.

F. van der Graaf, J. Michiels, W. Schroyens, 2002, International angiology : a journal of the International Union of Angiology.

Essential Thrombocythemia in Childhood

P. V. van Genderen, J. Michiels, J. Michiels, 1997, Seminars in thrombosis and hemostasis.

Transient neurological and ocular manifestations of primary thrombocythemia

P. Koudstaal, P. Koudstaal, J. Michiels, 1993 .

Primary myelofibrosis is not primary anymore since the discovery of MPL515 and CALR mutations as driver causes of mono-linear megakaryocytic and dual megakaryocytic granulocytic myeloproliferation and secondary myelofibrosis

J. Michiels, H. D. Raeve, 2019, International Journal of Bone Marrow Research.

European vs 2015-World Health Organization clinical molecular and pathological classification of myeloproliferative neoplasms

K. Schelfout, J. Michiels, F. Valster, 2015 .

Fibrin D-dimer testing for venous and arterial thrombotic disease.

G. Palareti, P. de Moerloose, J. Michiels, 2005, Seminars in vascular medicine.

Autosomal dominant erythermalgia associated with a novel mutation in the voltage-gated sodium channel alpha subunit Nav1.7.

J. Drenth, J. Jansen, J. Michiels, 2005, Archives of neurology.

Diagnostic Differentiation of von Willebrand Disease Types 1 and 2 by von Willebrand Factor Multimer Analysis and DDAVP Challenge Test

P. Smejkal, M. Penka, U. Budde, 2017, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Laboratory and Molecular Characteristics of Recessive von Willebrand Disease Type 2C (2A Subtype IIC) of Variable Severity due to Homozygous or Double Heterozygous Mutations in the D1 and D2 Domains

Z. Berneman, A. Gadisseur, J. Michiels, 2009, Acta Haematologica.

A novel type 2A von Willebrand factor mutation (V1499E) associated with variable clinical expression.

J. V. van Mourik, F. Versteegh, R. Schneppenheim, 2009, Journal of pediatric hematology/oncology.

Laboratory Diagnosis and Molecular Basis of Mild von Willebrand Disease Type 1

Z. Berneman, A. Gadisseur, J. Michiels, 2009, Acta Haematologica.

Platelets in Inflammation and Atherothrombosis

M. Gawaz, J. Michiels, 2007 .

Preface: platelets in inflammation and atherothrombosis.

M. Gawaz, J. Michiels, 2007, Seminars in thrombosis and hemostasis.

spondylitis . Jones proteinuria and ankylosing Renal AA amyloidosis in a patient with Bence

P. Siersema, J. Michiels, R. Quinton, 2004 .